The global Prokaryotic Expression System market size is predicted to grow from US$ 509 million in 2025 to US$ 702 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.
The prokaryotic system allows one to obtain large quantities of recombinant proteins in a short time. A simple and inexpensive bacterial cell culture and well-known mechanisms of transcription and translation facilitate the use of these microorganisms.For overproduction of recombinant proteins both eukaryotic and prokaryotic expression systems are used. Choosing the right system depends, among other things, on the growth rate and culture of host cells, level of the target gene expression and posttranslational processing of the synthesized protein. Regardless of the type of expression system, its basic elements are the vector and the expression host. The most widely used system for protein overproduction, both on a laboratory and industrial scale, is the prokaryotic system. This system is based primarily on the bacteria E. coli, although increasingly often Bacillus species are used. The prokaryotic system allows one to obtain large quantities of recombinant proteins in a short time. A simple and inexpensive bacterial cell culture and well-known mechanisms of transcription and translation facilitate the use of these microorganisms. The simplicity of genetic modifications and the availability of many bacterial mutants are additional advantages of the prokaryotic system. In this article we characterize the structural elements of prokaryotic expression vectors. Also strategies for preparation of the target protein gene that increase productivity, facilitate detection and purification of recombinant protein and provide its activity are discussed. Bacterial strains often used as host cells in expression systems as well as the potential location of heterologous proteins are characterized. Knowledge of the basic elements of the prokaryotic expression system allows for production of biologically active proteins in a short time and in satisfactory quantities.
The global prokaryotic expression system market refers to the market for systems and tools used for the expression of proteins in prokaryotic organisms, such as bacteria. Prokaryotic expression systems are widely used in biotechnology and pharmaceutical research for the production of recombinant proteins. The market is driven by several factors. Firstly, the increasing demand for recombinant proteins for research, diagnostics, and therapeutics drives the demand for prokaryotic expression systems. These systems allow for the efficient production of proteins in large quantities, which is essential for various applications in the life sciences. Secondly, the advancements in genetic engineering technologies have led to the development of improved prokaryotic expression systems. These systems enable the expression of complex proteins and facilitate the incorporation of post-translational modifications, enhancing the functionality of the produced proteins. Additionally, the growing investment in biotechnology and pharmaceutical research is fueling the demand for prokaryotic expression systems. Research organizations and pharmaceutical companies are actively engaged in discovering and developing new drugs and biological therapies that rely on recombinant proteins. Prokaryotic expression systems play a vital role in the production of these proteins. Furthermore, the increasing prevalence of chronic diseases, such as cancer and autoimmune disorders, has led to a rise in the demand for protein-based therapeutics. Prokaryotic expression systems offer a cost-effective and scalable solution for the production of these therapeutic proteins. Geographically, the market for prokaryotic expression systems is spread across regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market due to the presence of a well-established biotechnology and pharmaceutical industry. Europe and Asia Pacific follow closely, with significant investments in research and development activities.
The 鈥淧rokaryotic Expression System Industry Forecast鈥� looks at past sales and reviews total world Prokaryotic Expression System sales in 2024, providing a comprehensive analysis by region and market sector of projected Prokaryotic Expression System sales for 2025 through 2031. With Prokaryotic Expression System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prokaryotic Expression System industry.
This Insight Report provides a comprehensive analysis of the global Prokaryotic Expression System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prokaryotic Expression System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Prokaryotic Expression System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prokaryotic Expression System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prokaryotic Expression System.
This report presents a comprehensive overview, market shares, and growth opportunities of Prokaryotic Expression System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Fungi
Cell
Others
Segmentation by Application:
Biotech
Medicine
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
QIAGEN
Promega Corporation.
Thermo Fischer Scientific, Inc.
Life Technologies Corporation.
Takara Bio Inc.
GenScript
New England Biolabs.
OXFORD EXPRESSION TECHNOLOGIES LTD
LifeSensors, Proteogenix
Synthetic Genomics Inc.
Peak Proteins Ltd
ProMab, Sino Biological Inc.
Lucigen
ARTES Biotechnology GmbH
Jena Bioscience GmbH
BIONEER CORPORATION
LenioBio.
Lonza.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Prokaryotic Expression System 麻豆原创 Size (2020-2031)
2.1.2 Prokaryotic Expression System 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Prokaryotic Expression System by Country/Region (2020, 2024 & 2031)
2.2 Prokaryotic Expression System Segment by Type
2.2.1 Fungi
2.2.2 Cell
2.2.3 Others
2.3 Prokaryotic Expression System 麻豆原创 Size by Type
2.3.1 Prokaryotic Expression System 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Prokaryotic Expression System 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Prokaryotic Expression System Segment by Application
2.4.1 Biotech
2.4.2 Medicine
2.4.3 Laboratory
2.4.4 Others
2.5 Prokaryotic Expression System 麻豆原创 Size by Application
2.5.1 Prokaryotic Expression System 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Prokaryotic Expression System 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Prokaryotic Expression System 麻豆原创 Size by Player
3.1 Prokaryotic Expression System 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Prokaryotic Expression System Revenue by Player (2020-2025)
3.1.2 Global Prokaryotic Expression System Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Prokaryotic Expression System Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prokaryotic Expression System by Region
4.1 Prokaryotic Expression System 麻豆原创 Size by Region (2020-2025)
4.2 Global Prokaryotic Expression System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prokaryotic Expression System 麻豆原创 Size Growth (2020-2025)
4.4 APAC Prokaryotic Expression System 麻豆原创 Size Growth (2020-2025)
4.5 Europe Prokaryotic Expression System 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Prokaryotic Expression System 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Prokaryotic Expression System 麻豆原创 Size by Country (2020-2025)
5.2 Americas Prokaryotic Expression System 麻豆原创 Size by Type (2020-2025)
5.3 Americas Prokaryotic Expression System 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prokaryotic Expression System 麻豆原创 Size by Region (2020-2025)
6.2 APAC Prokaryotic Expression System 麻豆原创 Size by Type (2020-2025)
6.3 APAC Prokaryotic Expression System 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prokaryotic Expression System 麻豆原创 Size by Country (2020-2025)
7.2 Europe Prokaryotic Expression System 麻豆原创 Size by Type (2020-2025)
7.3 Europe Prokaryotic Expression System 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prokaryotic Expression System by Region (2020-2025)
8.2 Middle East & Africa Prokaryotic Expression System 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Prokaryotic Expression System 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Prokaryotic Expression System 麻豆原创 Forecast
10.1 Global Prokaryotic Expression System Forecast by Region (2026-2031)
10.1.1 Global Prokaryotic Expression System Forecast by Region (2026-2031)
10.1.2 Americas Prokaryotic Expression System Forecast
10.1.3 APAC Prokaryotic Expression System Forecast
10.1.4 Europe Prokaryotic Expression System Forecast
10.1.5 Middle East & Africa Prokaryotic Expression System Forecast
10.2 Americas Prokaryotic Expression System Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Prokaryotic Expression System Forecast
10.2.2 Canada 麻豆原创 Prokaryotic Expression System Forecast
10.2.3 Mexico 麻豆原创 Prokaryotic Expression System Forecast
10.2.4 Brazil 麻豆原创 Prokaryotic Expression System Forecast
10.3 APAC Prokaryotic Expression System Forecast by Region (2026-2031)
10.3.1 China Prokaryotic Expression System 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Prokaryotic Expression System Forecast
10.3.3 Korea 麻豆原创 Prokaryotic Expression System Forecast
10.3.4 Southeast Asia 麻豆原创 Prokaryotic Expression System Forecast
10.3.5 India 麻豆原创 Prokaryotic Expression System Forecast
10.3.6 Australia 麻豆原创 Prokaryotic Expression System Forecast
10.4 Europe Prokaryotic Expression System Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Prokaryotic Expression System Forecast
10.4.2 France 麻豆原创 Prokaryotic Expression System Forecast
10.4.3 UK 麻豆原创 Prokaryotic Expression System Forecast
10.4.4 Italy 麻豆原创 Prokaryotic Expression System Forecast
10.4.5 Russia 麻豆原创 Prokaryotic Expression System Forecast
10.5 Middle East & Africa Prokaryotic Expression System Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Prokaryotic Expression System Forecast
10.5.2 South Africa 麻豆原创 Prokaryotic Expression System Forecast
10.5.3 Israel 麻豆原创 Prokaryotic Expression System Forecast
10.5.4 Turkey 麻豆原创 Prokaryotic Expression System Forecast
10.6 Global Prokaryotic Expression System Forecast by Type (2026-2031)
10.7 Global Prokaryotic Expression System Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Prokaryotic Expression System Forecast
11 Key Players Analysis
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Information
11.1.2 Agilent Technologies, Inc. Prokaryotic Expression System Product Offered
11.1.3 Agilent Technologies, Inc. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Agilent Technologies, Inc. Main Business Overview
11.1.5 Agilent Technologies, Inc. Latest Developments
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Information
11.2.2 Bio-Rad Laboratories, Inc. Prokaryotic Expression System Product Offered
11.2.3 Bio-Rad Laboratories, Inc. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.2.5 Bio-Rad Laboratories, Inc. Latest Developments
11.3 QIAGEN
11.3.1 QIAGEN Company Information
11.3.2 QIAGEN Prokaryotic Expression System Product Offered
11.3.3 QIAGEN Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 QIAGEN Main Business Overview
11.3.5 QIAGEN Latest Developments
11.4 Promega Corporation.
11.4.1 Promega Corporation. Company Information
11.4.2 Promega Corporation. Prokaryotic Expression System Product Offered
11.4.3 Promega Corporation. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Promega Corporation. Main Business Overview
11.4.5 Promega Corporation. Latest Developments
11.5 Thermo Fischer Scientific, Inc.
11.5.1 Thermo Fischer Scientific, Inc. Company Information
11.5.2 Thermo Fischer Scientific, Inc. Prokaryotic Expression System Product Offered
11.5.3 Thermo Fischer Scientific, Inc. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Thermo Fischer Scientific, Inc. Main Business Overview
11.5.5 Thermo Fischer Scientific, Inc. Latest Developments
11.6 Life Technologies Corporation.
11.6.1 Life Technologies Corporation. Company Information
11.6.2 Life Technologies Corporation. Prokaryotic Expression System Product Offered
11.6.3 Life Technologies Corporation. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Life Technologies Corporation. Main Business Overview
11.6.5 Life Technologies Corporation. Latest Developments
11.7 Takara Bio Inc.
11.7.1 Takara Bio Inc. Company Information
11.7.2 Takara Bio Inc. Prokaryotic Expression System Product Offered
11.7.3 Takara Bio Inc. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Takara Bio Inc. Main Business Overview
11.7.5 Takara Bio Inc. Latest Developments
11.8 GenScript
11.8.1 GenScript Company Information
11.8.2 GenScript Prokaryotic Expression System Product Offered
11.8.3 GenScript Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 GenScript Main Business Overview
11.8.5 GenScript Latest Developments
11.9 New England Biolabs.
11.9.1 New England Biolabs. Company Information
11.9.2 New England Biolabs. Prokaryotic Expression System Product Offered
11.9.3 New England Biolabs. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 New England Biolabs. Main Business Overview
11.9.5 New England Biolabs. Latest Developments
11.10 OXFORD EXPRESSION TECHNOLOGIES LTD
11.10.1 OXFORD EXPRESSION TECHNOLOGIES LTD Company Information
11.10.2 OXFORD EXPRESSION TECHNOLOGIES LTD Prokaryotic Expression System Product Offered
11.10.3 OXFORD EXPRESSION TECHNOLOGIES LTD Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 OXFORD EXPRESSION TECHNOLOGIES LTD Main Business Overview
11.10.5 OXFORD EXPRESSION TECHNOLOGIES LTD Latest Developments
11.11 LifeSensors, Proteogenix
11.11.1 LifeSensors, Proteogenix Company Information
11.11.2 LifeSensors, Proteogenix Prokaryotic Expression System Product Offered
11.11.3 LifeSensors, Proteogenix Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 LifeSensors, Proteogenix Main Business Overview
11.11.5 LifeSensors, Proteogenix Latest Developments
11.12 Synthetic Genomics Inc.
11.12.1 Synthetic Genomics Inc. Company Information
11.12.2 Synthetic Genomics Inc. Prokaryotic Expression System Product Offered
11.12.3 Synthetic Genomics Inc. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Synthetic Genomics Inc. Main Business Overview
11.12.5 Synthetic Genomics Inc. Latest Developments
11.13 Peak Proteins Ltd
11.13.1 Peak Proteins Ltd Company Information
11.13.2 Peak Proteins Ltd Prokaryotic Expression System Product Offered
11.13.3 Peak Proteins Ltd Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Peak Proteins Ltd Main Business Overview
11.13.5 Peak Proteins Ltd Latest Developments
11.14 ProMab, Sino Biological Inc.
11.14.1 ProMab, Sino Biological Inc. Company Information
11.14.2 ProMab, Sino Biological Inc. Prokaryotic Expression System Product Offered
11.14.3 ProMab, Sino Biological Inc. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 ProMab, Sino Biological Inc. Main Business Overview
11.14.5 ProMab, Sino Biological Inc. Latest Developments
11.15 Lucigen
11.15.1 Lucigen Company Information
11.15.2 Lucigen Prokaryotic Expression System Product Offered
11.15.3 Lucigen Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Lucigen Main Business Overview
11.15.5 Lucigen Latest Developments
11.16 ARTES Biotechnology GmbH
11.16.1 ARTES Biotechnology GmbH Company Information
11.16.2 ARTES Biotechnology GmbH Prokaryotic Expression System Product Offered
11.16.3 ARTES Biotechnology GmbH Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 ARTES Biotechnology GmbH Main Business Overview
11.16.5 ARTES Biotechnology GmbH Latest Developments
11.17 Jena Bioscience GmbH
11.17.1 Jena Bioscience GmbH Company Information
11.17.2 Jena Bioscience GmbH Prokaryotic Expression System Product Offered
11.17.3 Jena Bioscience GmbH Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Jena Bioscience GmbH Main Business Overview
11.17.5 Jena Bioscience GmbH Latest Developments
11.18 BIONEER CORPORATION
11.18.1 BIONEER CORPORATION Company Information
11.18.2 BIONEER CORPORATION Prokaryotic Expression System Product Offered
11.18.3 BIONEER CORPORATION Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 BIONEER CORPORATION Main Business Overview
11.18.5 BIONEER CORPORATION Latest Developments
11.19 LenioBio.
11.19.1 LenioBio. Company Information
11.19.2 LenioBio. Prokaryotic Expression System Product Offered
11.19.3 LenioBio. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 LenioBio. Main Business Overview
11.19.5 LenioBio. Latest Developments
11.20 Lonza.
11.20.1 Lonza. Company Information
11.20.2 Lonza. Prokaryotic Expression System Product Offered
11.20.3 Lonza. Prokaryotic Expression System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Lonza. Main Business Overview
11.20.5 Lonza. Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.